ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.60
0.71%
US Tech 100
19,671.60
0.00%
S&P 500
5,770.20
0.55%
US Dollar vs CAD
1.43655
-0.04%
Bitcoin
82,538.01
2.42%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Indices
  4. FTSE
  5. FTSE 350 Pharmaceuticals and Biotechnology Index (NMX201030)

  6. FTSE 350 Pharmaceuticals and Biotechnology Index (NMX201030) Financials

NMX201030 FTSE 350 Pharmaceuticals and Biotechnology Index

22,829.31
0.00 (0.00%)
Mar 09 2025 - Closed
Delayed by 15 minutes
Company name:FTSE 350 Pharmaceuticals and Biotechnology Index
EPIC:NMX201030Trading Currency:GBP
Market Sector:ISIN:
Market Segment:Share Type:IX
WWW Address:Description:
Industry Sector:
 Price Price Change [%] Bid Ask Open High Low Volume
 22,829.31 images.advfn.com/imagesnew/2/us/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 - - - - - - - 24,740.05 - 19,079.65

FTSE 350 Pharmaceuticals... Key Figures

Key Figures
(at previous day's close)
Market Cap.-m
Shares In Issue-m
Prev. Close22,829.31
PE Ratio- 
Dividend Yield-%
EPS - basic-p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-p
Return On Equity (ROE)-%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt-m
Gross Gearing-%
Quick Assets-m
Net Working Capital-m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-p
Retained Profit PS-p
Cash PS-p
Net Cash PS-p
Net Tangible Asset Value PS *-p
Net Asset Value PS-p
Spread- (-%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

FTSE 350 Pharmaceuticals... Balance Sheet

%1$s Balance Sheet
Sorry No Data Available

Share Price Performance

Share Price Performance
Sample Period †HighLow
1 week22,967.4022,437.10
4 weeks22,967.4021,632.46
12 weeks22,967.4019,465.79
1 year24,740.0519,079.65

Share Price Chart (5 years)

Share Price Chart (5 years)

FTSE 350 Pharmaceuticals... Historic Returns

%1$s Historic Returns
Giorni da oggi †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week22,482.99346.321.5422,437.10--
4 weeks21,854.71974.604.4621,632.46--
12 weeks20,061.632,767.6813.8019,465.79--
26 weeks24,027.58-1,198.27-4.9919,079.65--
1 year20,608.452,220.8610.7819,079.65--
3 years18,800.144,029.1721.4318,246.33--
5 years16,031.796,797.5242.40119.33--
† periods calculated are whole weeks rather than calendar months

FTSE 350 Pharmaceuticals... Key Management Ratios

DEEPER ANALYSIS

FTSE 350 Pharmaceuticals... Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio - 
Tobin's Q Ratio (excl. intangibles)- 
Dividend Yield-%
Market-to-Book Ratio- 
Price-to-Pre-Tax Profit PS- 
Price-to-Retained Profit PS- 
Price-to-Cash Flow PS- 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS- 
Price-to-Cash PS- 
Net Working Capital PS- 
Price Pct to Working Capital PS-%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

FTSE 350 Pharmaceuticals... Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-%
Net Gearing (excl. Intangibles)-%
Gross Gearing-%
Gross Gearing (excl. Intangibles)-%
Gearing Under 1 Year-%
Gearing Under 1 Year (excl. Intgbl)-%
Assets/Equity- 
Cash/Equity- 
(Liquidity Ratios)
Net Working Capital to Total Assets-%
Current Ratio- 
Quick Ratio (Acid Test)- 
Liquidity Ratio- 
Cash & Equiv/Current Assets-%
(Solvency Ratios)
Enterprise Value-m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets- 
CFO/Debt- 
Total Debt/Equity Market Value- 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit- 
Total Debt-m
Total Debt/Net Current Assets-%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)
Sorry No Data AvailableSorry No Data Available

FTSE 350 Pharmaceuticals... Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)-%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-%
Return On Investment (ROI)-%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

FTSE 350 Pharmaceuticals... Dividends

Sorry No Data Available

FTSE 350 Pharmaceuticals... Fundamentals
Sorry No Data Available

FTSE 350 Pharmaceuticals... Balance Sheet

Sorry No Data Available

FTSE 350 Pharmaceuticals... Cash Flow Statement

Sorry No Data Available

FTSE 350 Pharmaceuticals... Brokers

Broker infomation is not available for this class of share.

Your Recent History

FTSE
NMX201030
FTSE 350 Pharmaceuticals...
USOTC
APYLF
Asiasec Properties (GM)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads